A high-dimensional cytometry atlas of peripheral blood over the human life span

Sedigheh Jalali1,2, Christopher M Harpur1, Adam T Piers1,3

  • 1Murdoch Children's Research Institute, Melbourne, VIC, Australia.

Insights

This study maps the human immune system from birth to age 75, revealing key changes in immune cell populations during childhood and adulthood. Understanding these shifts in immune cells is crucial for disease susceptibility and developing targeted therapies.

Area of Science:

  • Immunology
  • Human Physiology
  • Computational Biology

Background:

  • Age significantly impacts disease susceptibility and severity.
  • The developing immune system in children is not well understood compared to adults.
  • Immune cell composition is a key factor in disease outcomes.

Purpose of the Study:

  • To create a comprehensive immune cell atlas of the healthy human immune system across the lifespan (birth to 75 years).
  • To identify age-specific changes in immune cell populations, particularly in children.
  • To provide a reference for understanding immune system dynamics in health and disease.

Main Methods:

  • Utilized high-dimensional spectral flow cytometry to analyze over 50 immune cell populations.
  • Employed computational methods for data integration to build the immune cell atlas.
  • Focused analysis on peripheral blood samples from individuals across a wide age range.

Main Results:

  • Identified distinct patterns of immune cell changes from infancy through adolescence.
  • Specific immune cells (e.g., CD4+ T effector memory, Vδ2+ γδT, NK cells) showed age-specific peaks in childhood (5-18 years).
  • Observed unique immune cell profiles in early adulthood and late adulthood, including changes in T cells, B cells, and NK cells.

Conclusions:

  • The developed immune cell atlas provides a vital resource for understanding human immune system development and aging.
  • This atlas serves as a reference for investigating immune responses in various diseases.
  • Findings may inform the development of targeted immunotherapies for different age groups.